Viewing Study NCT03085368


Ignite Creation Date: 2025-12-24 @ 5:47 PM
Ignite Modification Date: 2026-02-27 @ 3:14 AM
Study NCT ID: NCT03085368
Status: UNKNOWN
Last Update Posted: 2017-07-28
First Post: 2017-03-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Randomized Controlled Trial of HER-2 Positive Breast Cancer Patients Treated With Lapatinib vs Herceptin
Sponsor: Peking Union Medical College Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HER2-positive Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None breast cancer View
None her-2 positive View
None lapatinib View
None herceptin View